A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
Saved in:
| Title: | A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis. |
|---|---|
| Authors: | Dampier CD; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA., Telen MJ; Division of Hematology, Duke Comprehensive Sickle Cell Center, Duke University Medical Center, Durham, NC., Wun T; Division of Hematology Oncology, UC Davis School of Medicine, Sacramento, CA., Brown RC; Department of Pediatrics, Emory University, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Atlanta, GA.; Children's Healthcare of Atlanta, Atlanta, GA., Desai P; James Comprehensive Cancer Hospital & Solove Research Institute, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH., El Rassi F; Georgia Comprehensive Sickle Cell Center and Grady Health System, Atlanta, GA.; Department of Medicine, Emory University, Atlanta, GA., Fuh B; East Carolina University Comprehensive Sickle Cell Center, Greenville, NC., Kanter J; Department of Medicine, University of Alabama, Birmingham, AL., Pastore Y; CHU Sainte-Justine, Montreal, QC, Canada.; Department of Pediatrics, University of Montreal, Montreal, QC, Canada., Rothman J; Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, NC., Taylor JG; Center for Sickle Cell Disease, Howard University College of Medicine, Washington, DC., Readett D; Pfizer Inc, Collegeville, PA., Sivamurthy KM; Pfizer Inc, Collegeville, PA., Tammara B; Pfizer Inc, Collegeville, PA., Tseng LJ; Pfizer Inc, New York, NY., Lozier JN; GlycoMimetics Inc, Rockville, MD., Thackray H; GlycoMimetics Inc, Rockville, MD., Magnani JL; GlycoMimetics Inc, Rockville, MD., Hassell KL; Division of Hematology, University of Colorado, Aurora, CO. |
| Corporate Authors: | RESET Investigators |
| Source: | Blood [Blood] 2023 Jan 12; Vol. 141 (2), pp. 168-179. |
| Publication Type: | Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
